Use of Pretreatment Perfusion MRI–based Intratumoral Heterogeneity to Predict Pathologic Response of Triple-Negative Breast Cancer to Neoadjuvant ChemoimmunotherapyToulsie Ramtohul, A. Tardivon, Emmanuelle Menet et al.|Radiology|2024Cited by 37
Prediction of pCR with pretreatment MRI radiomics in triple negative breast cancer treated with neoadjuvant chemo-immunotherapy.Toulsie Ramtohul, A. Tardivon, Victoire Lepagnay et al.|Journal of Clinical Oncology|2024Cited by 2